BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1581696)

  • 1. [Thrombin-antithrombin III complex. Cause of venous vascular occlusion of the retina].
    Krüger K; Anger V; Haas D
    Ophthalmologe; 1992 Feb; 89(1):67-70. PubMed ID: 1581696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitors of blood coagulation in vascular occlusion of the retina and optic nerve].
    Krüger K; Witt I
    Fortschr Ophthalmol; 1990; 87(2):178-81. PubMed ID: 2141589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin-antithrombin III complex in acute retinal vein occlusion.
    Iijima H; Gohdo T; Imai M; Tsukahara S
    Am J Ophthalmol; 1998 Nov; 126(5):677-82. PubMed ID: 9822231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombin-antithrombin III complexes in plasma and subretinal fluid in patients with perforated retinal detachment].
    Malukiewicz-Wiśniewska G; Kotschy M
    Klin Oczna; 2000; 102(4):267-70. PubMed ID: 11291298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay.
    Pelzer H; Schwarz A; Heimburger N
    Thromb Haemost; 1988 Feb; 59(1):101-6. PubMed ID: 3363526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of human thrombin-antithrombin III complex by enzyme immunoassay.
    Heimburger N; Pelzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):269-73. PubMed ID: 2465214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalent misconceptions about acute retinal vascular occlusive disorders.
    Hayreh SS
    Prog Retin Eye Res; 2005 Jul; 24(4):493-519. PubMed ID: 15845346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmodynamometric differences between ischemic vs nonischemic retinal vein occlusion.
    Jonas JB; Harder B
    Am J Ophthalmol; 2007 Jan; 143(1):112-6. PubMed ID: 17101111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated protein C resistance is a risk factor for central retinal vein occlusion.
    Marcucci R; Bertini L; Liotta AA; Rogolino A; Antonucci E; Ilari I; Pepe G; Prisco D
    Ann Ital Med Int; 2000; 15(3):195-8. PubMed ID: 11059059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases.
    Bertram B; Remky A; Arend O; Wolf S; Reim M
    Ger J Ophthalmol; 1995 Nov; 4(6):332-5. PubMed ID: 8751097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assay for thrombin-antithrombin III complexes in horses.
    Topper MJ; Prasse KW; Morris MJ; Duncan A; Crowe NA
    Am J Vet Res; 1996 Apr; 57(4):427-31. PubMed ID: 8712502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central retinal vein occlusion associated with cilioretinal artery occlusion.
    Hayreh SS; Fraterrigo L; Jonas J
    Retina; 2008 Apr; 28(4):581-94. PubMed ID: 18398361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of vascular surgery on values of thrombin-antithrombin III complexes in patients with atherosclerosis of lower limb arteries].
    Rość D; Zekanowska E; Kotschy M; Hryncewicz W; Jurkowska M
    Pol Tyg Lek; 1994 Apr 18-25; 49(16-17):360-2. PubMed ID: 7708552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increase of erythrocyte aggregation in retinal vein occlusion].
    Glacet-Bernard A; Chabanel A; Coscas G; Lelong F; Samama M
    J Fr Ophtalmol; 1990; 13(10):500-5. PubMed ID: 2081840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Laboratory diagnosis of left atrial thrombi in patients with mitral stenosis].
    Hayashi I
    Fukuoka Igaku Zasshi; 1991 Nov; 82(11):550-61. PubMed ID: 1774012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of latent changes in blood coagulation by the determination of plasma thrombin-antithrombin complex in gastrointestinal neoplasms].
    Guidi L; Bartoloni C; Pellicanò P; Cappelli A; Cursi F; Pili R; Tricerri A; Patriarca F; Gambassi G
    Clin Ter; 1991 Mar; 136(6):367-73. PubMed ID: 1828201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin activation fragment 1 + 2 and thrombin-antithrombin-III complexes in plasma of patients with essential arterial hypertension.
    Kłoczko J; Wojtukiewicz MZ; Galar M; Tarasów E; Jaromin J; Bielawiec M
    Pol J Pharmacol; 1996; 48(2):233-5. PubMed ID: 9112658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of the determination of several hemostatic parameters in the lacrimal fluid of patients with vascular diseases of the retina].
    Mukha AI; Markova OA
    Vestn Oftalmol; 1994; 110(1):19-20. PubMed ID: 8191655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factor VIII activity in patients with central retinal vein occlusion in comparison to patients with a history of pelvic and lower limb venous thrombosis and a healthy control group].
    Faude F; Faude S; Siegemund A; Wiedemann P
    Klin Monbl Augenheilkd; 2004 Oct; 221(10):862-6. PubMed ID: 15499522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.